Fractyl Health Inc stock is traded at $0.93, with a volume of 25,454. It is up +3.82% in the last 24 hours and down -79.65% over the past month. Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
Previous Close:
$0.8958
Open:
$0.8825
24h Volume:
25,454
Relative Volume:
0.06
Market Cap:
$12.34M
Revenue:
$3,000
Net Income/Loss:
-$108.00M
P/E Ratio:
-
EPS:
-$1.50
Net Cash Flow:
-$87.84M
1W Performance:
-4.76%
1M Performance:
-79.65%
6M Performance:
-89.46%
1Y Performance:
-92.89%
1-Day Range:
$0.8825$0.9484
1-Week Range:
$0.8702$0.9998
52-Week Range:
$0.8207$29.34
Fractyl Health Inc Stock (GUTS) Company Profile
Name
Fractyl Health IncSector
HealthcareIndustry
BiotechnologyPhone
781-902-8800Address
3 VAN DE GRAAFF DRIVE, BURLINGTON, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS